Zobrazeno 1 - 10
of 56
pro vyhledávání: '"David L Ahmann"'
Autor:
Robert T. Eagan, Harry F. Bisel, Jesse L. Steinfeld, John H. Edmonson, David L. Ahmann, William R. Taylor, Richard G. Hahn, Douglass C. Tormey
Publikováno v:
Cancer. 36:1925-1935
Ninety patients with advanced breast cancer received a polychemotherapeutic program composed of 5-fluorouracil, cyclophosphamide, and prednisone with or without vincristine as a control group in a series of four consecutive Phase II clinical trials o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf9177f528f41542432f8931c3f96c10
https://doi.org/10.1002/cncr.2820360601
https://doi.org/10.1002/cncr.2820360601
Publikováno v:
Cancer. 75:43-46
BACKGROUND: Data regarding the effects of estrogen replacement therapy (ERT) and its withdrawal in patients with breast cancer are limited. METHODS: Four cases were observed involving estrogen replacement therapy withdrawal as management of metastati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38907db46b9af43787e645824b16cb69
https://doi.org/10.1002/1097-0142(19950101)75:1<43::aid-cncr2820750109>3.0.co
https://doi.org/10.1002/1097-0142(19950101)75:1<43::aid-cncr2820750109>3.0.co
Autor:
D. T. Gilbertson, Nick J. Gonchoroff, James N. Ingle, Clive S. Grant, Jerry A. Katzmann, Lester E. Wold, David L. Ahmann, Terry M. Therneau, Thomas E. Witzig, Joseph P. Grande
Publikováno v:
Cancer. 68:1781-1788
The DNA content was analyzed in paraffin-embedded material from 167 patients with node-positive breast cancer to learn whether specimen sonication and multiparameter ploidy analysis (MPPA) (using DNA content and light scatter) could improve the stren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::790f9e74b60193da29bf9952aaa1597f
https://doi.org/10.1002/1097-0142(19911015)68:8<1781::aid-cncr2820680822>3.0.co
https://doi.org/10.1002/1097-0142(19911015)68:8<1781::aid-cncr2820680822>3.0.co
Autor:
David L. Ahmann
Publikováno v:
Adjuvant Therapy of Breast Cancer ISBN: 9781461365501
The initial treatment of primary breast cancer has already been covered adequately in previous chapters. This chapter proposes to examine the possible merits associated with the use of adjuvant systemic treatment (chemotherapy or hormonal therapy) in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93a45a6a58f11cbee643718dfac70ca7
https://doi.org/10.1007/978-1-4615-3496-9_6
https://doi.org/10.1007/978-1-4615-3496-9_6
Autor:
Daniel J. Schaid, Harry J. Long, Allan J. Schutt, Jan C. Buckner, David L. Ahmann, James N. Ingle, Joseph Rubin, Harry F. Bisel
Publikováno v:
American journal of clinical oncology. 14(3)
Ninety-four patients were entered in a clinical trial assessing the clinical activity of cyclophosphamide, doxorubicin, and prednisone (CAP) versus a combination of cyclophosphamide. 5-Fluorouracil, and prednisone (CFP) in patients with advanced brea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d0b96ce0c87ebd07acfd79466bffbb7
https://pubmed.ncbi.nlm.nih.gov/2031502
https://pubmed.ncbi.nlm.nih.gov/2031502
Publikováno v:
The Journal of investigative dermatology. 95
We have performed seven phase II trials with recombinant interferons (IFN) involving 191 patients with biopsy-proved, measurable disseminated malignant melanoma. The regimens and numbers of patients have included IFN-alpha 2A, 50 X 10(6) U/m2 subcuta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e9fc01f37f5c7085507f490a82ea06a
https://pubmed.ncbi.nlm.nih.gov/2124246
https://pubmed.ncbi.nlm.nih.gov/2124246
Publikováno v:
American journal of clinical oncology. 13(3)
Sixteen patients with advanced melanoma received IFN-alpha 2A, 36 X 10(6) U/m2 i.m., on days 3-7 with 2.25 g/m2 DFMO p.o. on days 1-7. We observed no objective regressions. Median time to progression was 1.2 months with a median survival of 5.2 month
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67809281039102ef5fb568dc2f87240b
https://pubmed.ncbi.nlm.nih.gov/2111969
https://pubmed.ncbi.nlm.nih.gov/2111969
Autor:
John C. Ivins, Thomas R. Fleming, David L. Ahmann, F H Sim, E O Burgert, E H Soule, John H. Edmonson, Michael J. O'Connell
Publikováno v:
Journal of Clinical Oncology. 2:1390-1396
Between June 1975 and April 1981, 61 of the 177 eligible patients whose nonosseous sarcomas of extremity or trunk origin had been completely excised primarily or after local recurrences agreed to participate in a randomized study of adjuvant chemothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3111c613b7387cce0235ca903682204
https://doi.org/10.1200/jco.1984.2.12.1390
https://doi.org/10.1200/jco.1984.2.12.1390
Autor:
Zofia E. Dziewanowski, Joseph Rubin, Edward T. Creagan, Harry J. Long, David L. Ahmann, Allan J. Schutt, Green Sj
Publikováno v:
Cancer. 54:2844-2849
Thirty-one patients with disseminated malignant melanoma received intramuscular recombinant leukocyte A interferon (rIFN-alpha A), 50 X 10(6) units/m2 three times weekly for a planned treatment duration of 3 months. Seven objective regressions (23%),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c006c1caab54b41ee0bb41382d0e034
https://doi.org/10.1002/1097-0142(19841215)54:12<2844::aid-cncr2820541205>3.0.co
https://doi.org/10.1002/1097-0142(19841215)54:12<2844::aid-cncr2820541205>3.0.co
Autor:
David L. Ahmann, Stephen A. Cullinan, James E. Krook, James N. Ingle, Judith R. O'Fallon, Jan C. Buckner, Delano M. Pfeifle, L K Everson
Publikováno v:
Breast Cancer Research and Treatment. 13:135-142
We have evaluated the results of salvage systemic therapy in 257 patients with breast cancer recurrent after surgical adjuvant treatment with cyclophosphamide, fluorouracil, and prednisone (CFP) with or without tamoxifen. The overall objective respon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b3d9c8ac303a023d7f728167518bb98
https://doi.org/10.1007/bf01806525
https://doi.org/10.1007/bf01806525